Latest Stock Market News

Gold and equities have displayed varying performances over decades. Gold often outshines during crisis, while equities thrive with economic growth. Analysis over extended periods and current Sensex-to-Gold Ratio indicates that well-diversified portfolios should leverage both assets to optimize wealth creation.

Sensex surged and Nifty ended its 10-day losing streak as signs of oversold conditions sparked a market rebound. Bluechip stocks led gains, with Coforge up 10%. While historical trends and technical indicators suggest a potential bottoming-out, skepticism remains amid ongoing global trade tensions and economic uncertainties.

The market has been in a corrective phase for the last five months, reminiscent of 1996. Investors should understand the valuation framework, which includes intrinsic and transaction values, to navigate these fluctuations successfully. Domestic-facing sectors like infrastructure and financials are promising for medium-to-long-term investments.

Gensol Engineering shares plunged 10% to a 52-week low of Rs 372.60 on the BSE, extending a 28% fall over two sessions. The drop followed CARE Ratings downgrade due to loan servicing delays. The stock has declined 63% from its peak, with technical indicators signaling continued weakness amid liquidity concerns and bearish momentum.

Bharat Electronics (BEL) has set March 11 as the record date to determine shareholder eligibility for its Rs 1.50 per share interim dividend. BEL stated that only shareholders holding shares by this date will receive the dividend. BEL s shares have seen a 28.97% increase over the past year but experienced a decline of 7.52% Year-To-Date.

Sanjeev Prasad discusses the current market, highlighting the lack of substantial value across large-cap, mid-cap, and small-cap indices despite their correction. He points out potential opportunities in the banking sector due to stabilization and growth prospects while cautioning against highly overvalued narrative stocks.

Coforge shares:The company has secured its largest deal to date, expected to contribute to revenue starting from Q1 FY26. If the deal progresses as projected, it could generate an additional $80–120 million in revenue for FY26, resulting in a 5–8% growth for the following year.

Ajay Bagga, Market Expert, highlights that NSE s shift of F&O expiry from Thursday to Monday from April 2025 will increase volatility and make trading strategies more complex for retail investors. The move appears competitive against BSE and will primarily benefit institutional players. Retail traders are advised to be cautious and adapt to the new dynamics.

​We have been cautious for a while so that is the reason we are getting brilliant opportunity to deploy money. Selectively, I am buyer in the stock including the smallcaps names.

The Nifty Pharma index was trading 0.8 per cent up at 19978.6.